Low-Dose Corticosteroid Use and Mortality in Severe Community-Acquired Pneumonia Patients

European Respiratory Journal - United Kingdom
doi 10.1183/09031936.00081514
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Severe Community-Acquired Pneumonia: Risk Factors for In-Hospital Mortality

Critical Care
Critical CareIntensive Care Medicine
2012English

Severe Community Acquired Pneumonia Update: Mortality, Mechanisms and Medical Intervention

Critical Care
Critical CareIntensive Care Medicine
2008English

One-Year Mortality in Patients With Community-Acquired Pneumonia

Journal of Respiratory Infections
2017English

Severe Sepsis in Community-Acquired Pneumonia

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2006English

Plasma Kallistatin Levels in Patients With Severe Community-Acquired Pneumonia

Critical Care
Critical CareIntensive Care Medicine
2013English

Hydrocortisone Infusion for Severe Community-Acquired Pneumonia

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2005English

Low Procalcitonin, Community Acquired Pneumonia, and Antibiotic Therapy

The Lancet Infectious Diseases
Infectious Diseases
2018English

Mortality Differences Among Hospitalized Patients With Community-Acquired Pneumonia in Three World Regions: Results From the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study

Respiratory Medicine
PulmonaryRespiratory Medicine
2013English

Prognostic Value of Proadrenomedullin in Severe Sepsis and Septic Shock Patients With Community-Acquired Pneumonia

Critical Care
Critical CareIntensive Care Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy